Byqlovi For Suspension
Product Images NDC 82667-021

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Byqlovi (NDC 82667-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Byq00 0000 01)

Chemical structure of clobetasol propionate showing the steroid backbone with fluorine, chlorine, hydroxyl, and ketone functional groups.*

FDA Label Image

Figure 1 (Byq00 0000 02)

This image contains two bar charts titled Study 1 and Study 2, each comparing the percentage of subjects at two analysis visits (P0D8 and P0D15) between BYQLOVI and a vehicle control. The charts show the proportion of subjects responding in both study groups over time.*

FDA Label Image

Figure 2 (Byq00 0000 03)

Two bar charts comparing the percentage of subjects over different analysis visits (POD4, POD8, POD15) between BYQLOVI and Vehicle groups. The vertical axis shows the percentage of subjects, with BYQLOVI consistently having higher percentages than Vehicle across all visits in both charts.*

FDA Label Image

Principal Display Panel (3.5 mL Carton Label)

Packaging label for BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05%, an ophthalmic suspension for topical application in the eye. The label shows a 3.5 mL sterile unit, Rx only, distributed by Harrow Eye, LLC, Nashville, TN. Directions include storage upright at 15°C to 25°C (59°F to 77°F) and warnings not to freeze or use if the tamper-evident overcap is not intact. Active ingredient is 0.5 mg/mL clobetasol propionate with listed inactives and preservative benzalkonium chloride.*

FDA Label Image

Principal Display Panel (3.5 mL Bottle Label)

Label for BYQLOVI (clobetasol propionate) ophthalmic suspension 0.05%, 3.5 mL. The label states it is for topical application in the eye and distributed by Harrow Eye, LLC, Nashville, TN. It includes storage instructions at 15°C to 25°C and warnings about tamper-evident overcap and freezing. The NDC is 82667-021-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.